News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Diamyd Medical AB Expands Its Scientific Advisory Board


6/13/2013 8:54:54 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Diamyd Medical recently acquired exclusive rights relating to the therapeutic use of GABA for the treatment of diabetes and other inflammation-related conditions. The Company is now expanding its Scientific and Medical Advisory Board with three internationally leading experts on GABA and diabetes: Dr. Bryndis Birnir, Dr. Brooke Ligon, and Dr. Qinghua Wang.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES